All-Trans Retinoic Acid-Loaded Fe–N3–Se Single-Atom Nanozymes Enable Redox-Guided Differentiation Therapy for Acute Myeloid Leukemia
ACS Nano · 03.11.2026
DOI: 10.1021/acsnano.6c09298 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 03.11.2026. Verfasst von Wei Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nanozyme Laboratory in Zhongyuan, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou450001, China. Hauptthemen laut MEDLINE: Tretinoin, Leukemia, Myeloid, Acute, Antineoplastic Agents, Selenium. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province, Fundamental Research Funds for the Central Universities, National Basic Research Program of China (973 Program).
Abstract (Originalsprache)
Differentiation blockade is a defining hallmark of acute myeloid leukemia (AML). While all-trans retinoic acid (ATRA)-based differentiation therapy is curative in acute promyelocytic leukemia (APL), its efficacy in non-APL AML remains limited, and the determinants of differentiation responsiveness beyond APL are poorly understood. Here, we identify redox homeostasis reprogramming as a decisive and previously underappreciated regulator of differentiation therapy efficacy in AML and establish nanozyme-enabled redox modulation as a generalizable framework to restore differentiation competence. We rationally design a Fe–Se dual-atom nanozyme that reconstructs key catalytic features of natural glutathione peroxidase, enabling controlled and homeostatic regulation of intracellular oxidative stress. When combined with ATRA, this redox-guided strategy reinstates differentiation-associated transcriptional programs, suppresses leukemic stemness, and overcomes intrinsic differentiation resistance independently of APL-specific oncogenic drivers. Efficacy is demonstrated in human AML xenograft models and a hoxa9-driven differentiation-arrest zebrafish model. Collectively, this work defines redox regulation as an actionable control point for extending differentiation-based therapies beyond genetically restricted AML subtypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanozyme Laboratory in Zhongyuan, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou450001, China.
- Nanozyme Laboratory in Zhongyuan, Henan Academy of Innovations in Medical Science, Zhengzhou, Henan451163, China.
- National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Central China Subcenter of National Center for Cardiovascular Diseases, Henan Cardiovascular Disease Center, Fuwai Central-China Cardiov…
- Department of Laboratory Medicine, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou310006, China.
- Zhejiang Key Laboratory of Zero Magnetic Medicine, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou310006, China.
- CAS Engineering Laboratory for Nanozyme, Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing100101, China.
ORCID-Profile: Xiyun Yan, Kelong Fan, Xiangmin Tong
Förderung
- Natural Science Foundation of Henan Province
- Fundamental Research Funds for the Central Universities
- National Basic Research Program of China (973 Program)
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Wang, W., Wang, S., Wang, S., Wang, S., Sun, G., Fan, X., Wang, S., Yan, X., Li, P., Fan, K., & Tong, X. (2026). All-Trans Retinoic Acid-Loaded Fe–N3–Se Single-Atom Nanozymes Enable Redox-Guided Differentiation Therapy for Acute Myeloid Leukemia. ACS Nano. https://doi.org/10.1021/acsnano.6c09298
Vancouver
Wang W, Wang S, Wang S, Wang S, Sun G, Fan X, et al. All-Trans Retinoic Acid-Loaded Fe–N3–Se Single-Atom Nanozymes Enable Redox-Guided Differentiation Therapy for Acute Myeloid Leukemia. ACS Nano. 2026. doi:10.1021/acsnano.6c09298
BibTeX
@article{Wang2026,
author = {Wang, Wei and Wang, Shuyu and Wang, Shang and Wang, Shuman and Sun, Guoming and Fan, Xiaowan and Wang, Shibing and Yan, Xiyun and Li, Peng and Fan, Kelong and Tong, Xiangmin},
title = {All-Trans Retinoic Acid-Loaded Fe–N3–Se Single-Atom Nanozymes Enable Redox-Guided Differentiation Therapy for Acute Myeloid Leukemia},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.6c09298}
}
EUVIMED